Craniopharyngioma
30
9
12
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 30 trials
100.0%
+13.5% vs benchmark
3%
1 trials in Phase 3/4
25%
3 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (30)
A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection
Methionine PET/CT Studies In Patients With Cancer
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
Food Preferences and Craniopharyngiomas
Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
Molecular-Guided Therapy for Childhood Cancer
ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Long-Term Longitudinal QoL in Patients Undergoing EEA
The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
Craniopharyngioma and Pregnancies
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology
Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts
Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
Management of Pediatric Craniopharyngioma by a Combination of Partial Surgical Resection, and Protontherapy (Craniopharyngioma)
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
Intranasal Oxytocin in Hypothalamic Obesity